Article Details
Retrieved on: 2024-12-02 21:13:37
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article explores Gilead Sciences' use of machine learning and generative AI in drug discovery and internal processes. It discusses how AWS services enhance data management, increasing productivity and optimizing drug discovery, linking to AI, cloud, and biotech advancements.
Article found on: emerj.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here